Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin

Published 2018 View Full Article

Authors

Keywords

Niemann-Pick disease, Type C1, NPC1, Necroptosis, RIP kinase, RIPK1, RIPK3, 2-hydroxypropyl-β-cyclodextrin

Journal

MOLECULAR GENETICS AND METABOLISM

Volume 125, Issue 4, Pages 345-350

Publisher

Elsevier BV

Online

2018-10-31

DOI

10.1016/j.ymgme.2018.10.009

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now